Castle Biosciences (CSTL) Free Cash Flow by Year
Castle Biosciences generated $28.3M in free cash flow in fiscal year 2025. This represents a decrease of 22.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $489K in free cash flow. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Castle Biosciences has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CSTL Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
CSTL Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Castle Biosciences financials
Frequently Asked Questions
What was Castle Biosciences's free cash flow in fiscal year 2025?
Castle Biosciences generated $28.3M in free cash flow in fiscal year 2025.
How fast is Castle Biosciences's free cash flow growing?
Castle Biosciences (CSTL) free cash flow fell by 22.5% year over year, from $36.5M to $28.3M in fiscal year 2025.
What is Castle Biosciences's free cash flow over the last twelve months?
Castle Biosciences (CSTL) reported an outflow of $489K in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Castle Biosciences's free cash flow changed over the years?
Across the 8 fiscal years this page covers, Castle Biosciences (CSTL) free cash flow went from -$12.6M in fiscal year 2018 to $28.3M in fiscal year 2025.
What was Castle Biosciences's free cash flow in the most recent quarter?
Castle Biosciences (CSTL) reported $6.6M in free cash flow in Q2 2026. This represents a decrease of 43.3% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Castle Biosciences (CSTL) reported on that line in every period on record.